Abstract
BackgroundThe IL6-antibody tolicizumab (TCZ) leads to a rapid improvement of the clinical course in patients with rheumatoid arthritis (RA) as assessed by the DAS28 score.4 However, in MR and ultrasound...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have